Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020.
Kopra EI, Ferris JA, Winstock AR, Kuypers KP, Young AH, Rucker JJ
Publication record · Explore literaturePublic tracker catalogue and stored structured reference metadata. External references may have identifiers only. No live external citation lookup is performed.
References — this paper cites (0)
No references identified in the available metadata. This does not establish that none exist.
Cited by — these papers cite this paper (5)
- Naturally Derived Psilocybin for Therapeutic Use: A Six-Criterion Framework for Evidence, Safety, and Benefit-Risk Considerations in Policy and Clinical Development 2026-07-03 · Expand citations
- “You can only take your clients as far as you’ve been yourself”: examining the intersections between psychedelic-assisted therapy, lived-living experience, and clinical practice 2026-03-22 · Expand citations
- Beyond prohibition: A public health analysis of naturalistic psychedelic use 2025-07-03 · Expand citations
- Exploring the perceived usefulness of integration support after naturalistic psychedelic experiences in people concerned about their substance use: A survey 2025-04-22 · Expand citations
- Extended difficulties following the use of psychedelic drugs: A mixed methods study 2023-10-23 · Expand citations